Kukje Pharma Co., Ltd. (KRX:002720)

South Korea · Delayed Price · Currency is KRW

3,310.00

+35.00 (1.07%)

Last updated: Aug 6, 2026, 2:35 PM KST

Kukje Pharma Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	177,972	175,496	156,463	135,373	126,583	119,746
Revenue Growth	10.93%	12.16%	15.58%	6.94%	5.71%	-8.17%
Gross Profit	95,080	93,645	82,495	67,225	63,254	54,470
Operating Income	5,850	6,185	6,702	-1,989	5,273	-1,676
Net Income	5,992	5,698	5,205	-8,415	3,557	-1,559
Earnings Per Share	291.15	279.51	256.00	-415.49	175.58	-77.14
EPS Growth	37.38%	9.18%	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	9,377	10,724	8,755	10,632	5,559	7,903
Total Debt	30,920	30,404	29,512	30,662	28,596	35,987
Net Cash (Debt)	-21,543	-19,680	-20,757	-20,030	-23,037	-28,084
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1046.71	-965.47	-1020.85	-988.96	-1137.06	-1385.71

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2,927	5,835	3,940	3,575	6,504	9,597
Capital Expenditures	-3,859	-3,619	-2,911	-1,046	-1,259	-1,892
Free Cash Flow	-932.07	2,216	1,029	2,529	5,245	7,705
Free Cash Flow Growth	-	115.42%	-59.32%	-51.78%	-31.93%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	53.42%	53.36%	52.73%	49.66%	49.97%	45.49%
Operating Margin	3.29%	3.52%	4.28%	-1.47%	4.17%	-1.40%
Pretax Margin	3.84%	3.67%	4.22%	-4.93%	3.75%	-0.93%
Profit Margin	3.37%	3.25%	3.33%	-6.22%	2.81%	-1.30%
FCF Margin	-0.52%	1.26%	0.66%	1.87%	4.14%	6.43%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	11.25	15.37	19.80	-	29.83	-
P/FCF Ratio	-	39.51	100.14	47.40	20.23	14.65
PS Ratio	0.37	0.50	0.66	0.89	0.84	0.94